vida: extract claims from 2026-04-14-kennedy-forum-mhparity-index-national-launch-full-data

- Source: inbox/queue/2026-04-14-kennedy-forum-mhparity-index-national-launch-full-data.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 4
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/behavioral-glp1-companion-programs-achieve-0-8-percent-weight-maintenance-post-discontinuation-versus-11-12-percent-regain-proving-standalone-behavioral-value.md

@@ -0,0 +1,19 @@
+---
+type: claim
+domain: health
+description: Omada's data shows behavioral support creates durable outcomes independent of continued medication use, reframing the value proposition from medication management to lasting behavioral change
+confidence: experimental
+source: Omada Health clinical outcomes data, March 2026 announcement
+created: 2026-05-02
+title: Behavioral GLP-1 companion programs achieve 0.8 percent average weight change at one year post-discontinuation versus 11-12 percent regain in clinical trials proving standalone behavioral value
+agent: vida
+sourced_from: health/2026-03-05-omada-glp1-flex-care-employer-cash-pay-model.md
+scope: causal
+sourcer: Omada Health
+supports: ["comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation"]
+related: ["glp1-long-term-persistence-ceiling-14-percent-year-two", "comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation", "digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring", "digital-behavioral-support-enables-glp1-dose-reduction-while-maintaining-clinical-outcomes", "glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics", "glp-1-receptor-agonists-require-continuous-treatment-because-metabolic-benefits-reverse-within-28-52-weeks-of-discontinuation"]
+---
+
+# Behavioral GLP-1 companion programs achieve 0.8 percent average weight change at one year post-discontinuation versus 11-12 percent regain in clinical trials proving standalone behavioral value
+
+Omada Health reports that members who discontinued GLP-1 receptor agonists but continued behavioral support showed 0.8% average weight change at one year, compared to 11-12% weight regain observed in clinical trials without behavioral support (STEP-1 extension data). This 10-14x difference in post-discontinuation outcomes demonstrates that the behavioral companion program has standalone value independent of medication persistence. The clinical significance is that behavioral support is not merely medication adherence scaffolding but a durable intervention that modifies eating patterns, activity levels, and metabolic health even after pharmacological support ends. This evidence supports the economic viability of the Flex Care model: employers are purchasing lasting behavioral change, not just medication management infrastructure. The data comes from Omada's real-world member population, not a randomized trial, so selection effects may exist (members who continue behavioral support post-discontinuation may differ from those who don't). However, the magnitude of the difference (0.8% vs. 11-12%) is large enough to suggest a genuine effect beyond selection. This reframes the GLP-1 behavioral support value proposition: instead of 'helping people stay on expensive medications,' it becomes 'creating durable metabolic and behavioral improvements that persist even if medication access is lost.' This is critical for the cash-pay model's viability—if behavioral support only worked while patients were on medication, employers would have no reason to fund it separately.

domains/health/digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring.md

@@ -53,3 +53,10 @@ Omada's Enhanced GLP-1 Care Track achieved 67% persistence at 12 months versus 4
 **Source:** Noom 2025 performance data, Pharmaceutical Commerce
 
 Noom's microdose GLP-1Rx users showed 77.8% engagement with the app for 4+ weeks, with December cohort D30 engagement at 43.6% (10x+ higher than average health/medical/fitness app retention of 4.3%). The company identified side effect management as the primary cause of 30%+ dropout in first 4 weeks during titration phase, and addressed this through microdosing strategy (lower dose → fewer side effects → higher adherence) rather than purely behavioral interventions.
+
+
+## Extending Evidence
+
+**Source:** Omada Health clinical outcomes data, March 2026
+
+Omada members who persisted on GLP-1 for 12 months achieved 18.4% average weight loss and 44% greater weight loss on semaglutide versus real-world evidence, suggesting behavioral support improves not just persistence but also on-medication efficacy.

domains/health/employer-glp1-cash-pay-model-separates-program-cost-from-medication-cost-enabling-behavioral-support-without-drug-benefit-exposure.md

@@ -0,0 +1,19 @@
+---
+type: claim
+domain: health
+description: Omada's Flex Care model allows employers to purchase behavioral support while employees pay for medications independently, creating a new access pathway that bypasses the covered lives decline problem
+confidence: experimental
+source: Omada Health GLP-1 Flex Care announcement, March 2026
+created: 2026-05-02
+title: Employer GLP-1 cash-pay models separate behavioral program costs from medication costs enabling employers to fund support infrastructure without direct drug benefit exposure
+agent: vida
+sourced_from: health/2026-03-05-omada-glp1-flex-care-employer-cash-pay-model.md
+scope: structural
+sourcer: Omada Health
+supports: ["glp1-employer-coverage-declining-despite-utilization-growth-creating-access-gap", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation"]
+related: ["glp1-employer-coverage-declining-despite-utilization-growth-creating-access-gap", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary", "glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift"]
+---
+
+# Employer GLP-1 cash-pay models separate behavioral program costs from medication costs enabling employers to fund support infrastructure without direct drug benefit exposure
+
+Omada Health's GLP-1 Flex Care represents a structural financial innovation in response to the documented employer covered lives decline (3.6M to 2.8M). The model unbundles the behavioral program cost from medication cost: employers pay for clinical evaluation, prescribing, medical oversight, and behavioral coaching, while employees purchase GLP-1 medications through cash-pay channels or their own pharmacy benefits. This eliminates employer exposure to the direct medication costs that drove the coverage withdrawal documented in prior sessions. The innovation is not clinical but financial—it creates a purchasing structure that allows employers who dropped GLP-1 coverage due to cost pressure to re-enter the market by funding only the behavioral infrastructure. This addresses the access paradox where employers want to support weight management but cannot absorb the 10x PMPM increase from medication costs. The model is deployable across pharmacy benefits, direct-to-employer, and other purchasing channels, making it a flexible response to heterogeneous employer benefit structures. Availability begins later in 2026, so real-world adoption data does not yet exist, but the structural logic directly addresses the documented barrier: employers can now purchase the behavioral companion without the medication liability that caused the covered lives contraction.

domains/health/glp1-employer-coverage-declining-despite-utilization-growth-creating-access-gap.md

@@ -53,3 +53,10 @@ Reconciliation of apparent contradiction: KFF shows 49% large employer coverage
 **Source:** NPR April 22, 2026; Mercer 2026
 
 NPR provides second-source confirmation of the covered lives decline: 3.6M (2024) → 2.8M (2026), a 22% drop. Multiple employers in NPR focus groups reported firms 'will no longer cover GLP-1 agonists for weight loss.' The Mercer data shows 66% of employers say GLP-1 had 'significant' impact on prescription drug spending, and 77% of large employers prioritize managing GLP-1 costs. This confirms the access gap is widening despite clinical demand growth.
+
+
+## Extending Evidence
+
+**Source:** Omada Health GLP-1 Flex Care announcement, March 2026
+
+Omada's Flex Care model represents the first documented employer purchasing structure designed specifically to address the covered lives decline. By separating behavioral program costs from medication costs, it creates a pathway for employers to re-enter GLP-1 support without the 10x PMPM medication liability that drove the 3.6M to 2.8M contraction.

domains/health/glp1-managed-access-infrastructure-creates-distinct-platform-opportunity-beyond-behavioral-coaching.md

@@ -10,9 +10,16 @@ agent: vida
 sourced_from: health/2026-04-28-phti-employer-glp1-coverage-behavioral-mandate-2025.md
 scope: structural
 sourcer: Peterson Health Technology Institute
-related: ["glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024"]
+related: ["glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "glp1-managed-access-infrastructure-creates-distinct-platform-opportunity-beyond-behavioral-coaching", "federal-glp1-expansion-programs-reproduce-access-hierarchy-at-design-level"]
 ---
 
 # GLP-1 managed-access infrastructure layer creates a distinct platform opportunity separate from behavioral coaching
 
 PHTI identifies five infrastructure components required for managed GLP-1 access: (1) utilization management infrastructure, (2) outcomes-based contracting frameworks, (3) indication-specific cardiometabolic programs (CVD, OSA, MASH, perimenopause, prediabetes), (4) adherence, tapering, and discontinuation management systems, and (5) employer-side financing or subsidy products. This is architecturally distinct from behavioral coaching. The report describes payers building 'managed-access operating systems' that determine which populations qualify, through which channels, with what behavioral gates, at what subsidy levels, and with what discontinuation rules. This is not a feature—it's a platform. The infrastructure layer exists because traditional yes/no formulary decisions cannot accommodate GLP-1 economics (36.2M eligible × $1,000-1,200/month). Three major payers (Evernorth, Optum Rx, UHC) have operationalized distinct infrastructure plays, not just coaching partnerships. The platform opportunity is separate from the behavioral coaching layer because it operates at the payer-employer interface, not the patient-provider interface.
+
+
+## Extending Evidence
+
+**Source:** Omada Health GLP-1 Flex Care announcement, March 2026
+
+Omada's Flex Care model demonstrates that managed access infrastructure can be monetized through employer direct purchasing even when medication costs are externalized, proving the platform value exists independent of medication benefit administration.

domains/health/illinois-mhpaea-2024-rule-enforcement-creates-natural-experiment-for-outcome-data-evaluation.md

@@ -10,9 +10,16 @@ agent: vida
 sourced_from: health/2025-07-01-illinois-idoi-company-bulletin-2025-10-mhpaea-2024-rule-enforcement.md
 scope: experimental
 sourcer: Illinois Department of Insurance
-related: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates", "state-mhpaea-enforcement-addresses-procedural-parity-not-reimbursement-parity", "trump-mhpaea-2024-rule-pause-suspends-outcome-data-enforcement-preserves-procedural-compliance"]
+related: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates", "state-mhpaea-enforcement-addresses-procedural-parity-not-reimbursement-parity", "trump-mhpaea-2024-rule-pause-suspends-outcome-data-enforcement-preserves-procedural-compliance", "illinois-mhpaea-2024-rule-enforcement-creates-natural-experiment-for-outcome-data-evaluation", "mhpaea-enforcement-evolved-three-levels-coverage-access-metrics-reimbursement"]
 ---
 
 # Illinois's enforcement of the paused 2024 MHPAEA Final Rule creates a natural experiment for whether outcome data evaluation can change insurer reimbursement practices for mental health providers
 
 On May 15, 2025, HHS announced it would not enforce amendments to MHPAEA regulations from the 2024 Final Rule, specifically the outcome data evaluation requirements designed to detect reimbursement rate discrimination. HHS encouraged but did not require states to adopt the same non-enforcement approach. Illinois DOI responded with Company Bulletin 2025-10 announcing it would NOT waive or defer enforcement on ANY provision of the 2024 Final Rule for health insurers and HMOs under state law. The legal basis: the 2024 Final Rule has not been formally repealed, overturned by a court, or superseded by federal legislation or replacement rules, so Illinois law and public policy require continued enforcement. The specific provisions Illinois continues enforcing are the outcome data evaluation requirements and new NQTL standards—precisely the provisions that would bridge the coverage-design vs. reimbursement-rate gap in the two-level access problem. Illinois DOI has contracted with Health Services Advisory Group (HSAG) to conduct a Mental Health Parity Analysis of all HealthChoice Illinois and Youth Care health plans, assessing processes for MHPAEA compliance including the 2024 rule's outcome data evaluation requirements. This creates a natural experiment: Illinois (full 2024 rule enforcement) vs. states following the federal pause. If Illinois shows measurable improvement in mental health access metrics over 2-3 years, it would provide the strongest evidence yet that outcome-based enforcement can address the two-level access problem. The experiment is structurally sound because HHS explicitly said it 'encouraged but did not require' states to follow the pause—the 2024 rule remains legally in force at the state level for states that choose to enforce it.
+
+
+## Extending Evidence
+
+**Source:** Kennedy Forum Mental Health Parity Index, April 2026
+
+New York State committed to examining in-depth Mental Health Parity Index metrics for its 11 million commercially insured citizens (with support from NY Community Trust), creating a second natural experiment alongside Illinois. Illinois conducted full enforcement deep-dive analysis, while New York is pursuing deep-dive analysis without the enforcement commitment—allowing comparison of transparency-only versus transparency-plus-enforcement approaches.

domains/health/mental-health-reimbursement-27pct-gap-structural-access-barrier.md

@@ -10,27 +10,9 @@ agent: vida
 sourced_from: health/2026-04-30-rti-kennedy-forum-mental-health-reimbursement-27pct-gap.md
 scope: structural
 sourcer: RTI International / The Kennedy Forum
-supports:
-- mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates
-- the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access
-- mhpaea-enforcement-evolved-three-levels-coverage-access-metrics-reimbursement
-- Colorado HB 25-1002 establishes the first state-level outcomes data testing authority for behavioral health parity enforcement, creating a potential natural experiment for access-metric enforcement
-- Mental Health Parity Index
-- The Mental Health Parity Index documents that 43 states have structural access disparities in commercial insurance driven by below-Medicare reimbursement rates, not just coverage design failures
-related:
-- mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates
-- the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access
-- mental-health-reimbursement-27pct-gap-structural-access-barrier
-- state-mhpaea-enforcement-addresses-procedural-parity-not-reimbursement-parity
-- mhpaea-enforcement-evolved-three-levels-coverage-access-metrics-reimbursement
-- Colorado HB 25-1002
-- Reimbursement benchmarking tools are the necessary but missing infrastructure for outcome-based MHPAEA enforcement
-reweave_edges:
-- Colorado HB 25-1002|related|2026-05-02
-- Colorado HB 25-1002 establishes the first state-level outcomes data testing authority for behavioral health parity enforcement, creating a potential natural experiment for access-metric enforcement|supports|2026-05-02
-- Mental Health Parity Index|supports|2026-05-02
-- The Mental Health Parity Index documents that 43 states have structural access disparities in commercial insurance driven by below-Medicare reimbursement rates, not just coverage design failures|supports|2026-05-02
-- Reimbursement benchmarking tools are the necessary but missing infrastructure for outcome-based MHPAEA enforcement|related|2026-05-02
+supports: ["mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates", "the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access", "mhpaea-enforcement-evolved-three-levels-coverage-access-metrics-reimbursement", "Colorado HB 25-1002 establishes the first state-level outcomes data testing authority for behavioral health parity enforcement, creating a potential natural experiment for access-metric enforcement", "Mental Health Parity Index", "The Mental Health Parity Index documents that 43 states have structural access disparities in commercial insurance driven by below-Medicare reimbursement rates, not just coverage design failures"]
+related: ["mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates", "the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access", "mental-health-reimbursement-27pct-gap-structural-access-barrier", "state-mhpaea-enforcement-addresses-procedural-parity-not-reimbursement-parity", "mhpaea-enforcement-evolved-three-levels-coverage-access-metrics-reimbursement", "Colorado HB 25-1002", "Reimbursement benchmarking tools are the necessary but missing infrastructure for outcome-based MHPAEA enforcement", "mental-health-parity-index-documents-43-states-structural-access-disparities-driven-by-below-medicare-reimbursement", "reimbursement-benchmarking-tools-necessary-missing-infrastructure-outcome-based-mhpaea-enforcement"]
+reweave_edges: ["Colorado HB 25-1002|related|2026-05-02", "Colorado HB 25-1002 establishes the first state-level outcomes data testing authority for behavioral health parity enforcement, creating a potential natural experiment for access-metric enforcement|supports|2026-05-02", "Mental Health Parity Index|supports|2026-05-02", "The Mental Health Parity Index documents that 43 states have structural access disparities in commercial insurance driven by below-Medicare reimbursement rates, not just coverage design failures|supports|2026-05-02", "Reimbursement benchmarking tools are the necessary but missing infrastructure for outcome-based MHPAEA enforcement|related|2026-05-02"]
 ---
 
 # Mental health providers are reimbursed 27.1% less than medical/surgical providers for comparable services creating a structural access barrier that MHPAEA enforcement cannot address because the law requires comparable processes not comparable rates
@@ -49,4 +31,10 @@ Colorado HB 25-1002's outcomes data testing authority creates a potential enforc
 
 **Source:** Mental Health Parity Index, April 2026
 
-Mental Health Parity Index (April 2026) provides first national tool measuring access disparities at state/county level using reimbursement benchmarks, confirming majority of MH/SUD clinicians paid below Medicare rates. This creates systematic measurement infrastructure for the reimbursement gap previously documented only through RTI International/Kennedy Forum research.
+Mental Health Parity Index (April 2026) provides first national tool measuring access disparities at state/county level using reimbursement benchmarks, confirming majority of MH/SUD clinicians paid below Medicare rates. This creates systematic measurement infrastructure for the reimbursement gap previously documented only through RTI International/Kennedy Forum research.
+
+## Extending Evidence
+
+**Source:** Kennedy Forum Mental Health Parity Index, April 2026
+
+Mental Health Parity Index reveals reimbursement gap is not a single 27.1% figure but a distribution ranging from 16% to 59% across the four largest US commercial insurers (Aetna, BCBS, Cigna, UnitedHealthcare). ALL 50 states demonstrate lower payment for outpatient MH/SUD treatment than physical health, with some insurers paying 59% below parity—a gap so extreme it's legally indefensible under MHPAEA regardless of enforcement status. The range width indicates massive insurer-to-insurer variation, meaning some plans are near parity while others are catastrophically misaligned.

domains/health/trump-mhpaea-2024-rule-pause-suspends-outcome-data-enforcement-preserves-procedural-compliance.md

@@ -54,4 +54,10 @@ The Kaiser settlement creates a nuanced enforcement posture under Trump DOL: out
 
 **Source:** Synthesis of 2024 Final Rule provisions
 
-The paused 2024 rule's outcome data evaluation requirement was the specific mechanism designed to connect Level 1.5 measurement (access metrics) to Level 2 remediation (reimbursement rates) by requiring insurers to identify and fix underlying causes when outcome data shows persistent access gaps despite NQTL compliance. The pause removes this connection mechanism.
+The paused 2024 rule's outcome data evaluation requirement was the specific mechanism designed to connect Level 1.5 measurement (access metrics) to Level 2 remediation (reimbursement rates) by requiring insurers to identify and fix underlying causes when outcome data shows persistent access gaps despite NQTL compliance. The pause removes this connection mechanism.
+
+## Extending Evidence
+
+**Source:** Kennedy Forum Mental Health Parity Index, April 2026
+
+As of April 2026, federal health officials confirmed they will not enforce the parity law (Trump administration pause of 2024 MHPAEA Final Rule enforcement). The Mental Health Parity Index is creating a parallel transparency and accountability infrastructure to compensate for federal enforcement withdrawal, using real-time data from in-network payer files to document violations state-by-state.

inbox/archive/health/2026-03-05-omada-glp1-flex-care-employer-cash-pay-model.md

@@ -7,11 +7,14 @@ date: 2026-03-05
 domain: health
 secondary_domains: [internet-finance]
 format: press-release
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-05-02
 priority: medium
 tags: [Omada, GLP-1, employer-market, cash-pay, behavioral-health, covered-lives, employer-benefits]
 intake_tier: research-task
 flagged_for_rio: ["employer benefits financing structure — cash-pay vs. traditional benefits design is a financial mechanism question"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content

inbox/archive/health/2026-04-14-kennedy-forum-mhparity-index-national-launch-full-data.md

@@ -7,10 +7,13 @@ date: 2026-04-14
 domain: health
 secondary_domains: []
 format: press-release
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-05-02
 priority: high
 tags: [mental-health, parity, MHPAEA, reimbursement, access, insurance, Kennedy-Forum]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content